MDGL
Madrigal Pharmaceuticals (MDGL)
$04
About Madrigal Pharmaceuticals (MDGL)
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.
Details
Daily high
$517.32
Daily low
$502.78
Price at open
$511.97
52 Week High
$615.00
52 Week Low
$342.73
Market cap
11.8B
Dividend yield
0.00%
Volume
347,529
Avg. volume
382,640
P/E ratio
-39.59
Madrigal Pharmaceuticals News
Details
Daily high
$517.32
Daily low
$502.78
Price at open
$511.97
52 Week High
$615.00
52 Week Low
$342.73
Market cap
11.8B
Dividend yield
0.00%
Volume
347,529
Avg. volume
382,640
P/E ratio
-39.59